The time has come for revising the rules of clozapine blood monitoring in Europe. A joint expert statement from the European Clozapine Task Force

  1. Verdoux, H.
  2. Bittner, R.A.
  3. Hasan, A.
  4. Qubad, M.
  5. Wagner, E.
  6. Lepetit, A.
  7. Arrojo-Romero, M.
  8. Bachmann, C.
  9. Beex-Oosterhuis, M.
  10. Bogers, J.
  11. Celofiga, A.
  12. Cohen, D.
  13. De Berardis, D.
  14. De Hert, M.
  15. De Las Cuevas, C.
  16. Ebdrup, B.H.
  17. Fountoulakis, K.N.
  18. Guinart, D.
  19. Keating, D.
  20. Kopeček, M.
  21. Lally, J.
  22. Lazáry, J.
  23. Luykx, J.J.
  24. Maronas Amigo, O.
  25. Molden, E.
  26. Nielsen, J.
  27. O'donoghue, B.
  28. Oswald, P.
  29. Radulescu, F.S.
  30. Rohde, C.
  31. Sagud, M.
  32. Sanz, E.J.
  33. Šimunović Filipčić, I.
  34. Sommer, I.E.
  35. Taipale, H.
  36. Tiihonen, J.
  37. Tuppurainen, H.
  38. Veerman, S.
  39. Wilkowska, A.
  40. Spina, E.
  41. Schulte, P.
  42. Show all authors +
Journal:
European Psychiatry

ISSN: 1778-3585,  0924-9338

Year of publication: 2025

Volume: 68

Issue: 1

Type: Article

DOI: 10.1192/J.EURPSY.2024.1816 GOOGLE SCHOLAR lock_openOpen access editor
Data source: Scopus